When should asymptomatic patients with HIV infection be treated with zidovudine? - Wikidata - wikimedia - TriplyDB

When should asymptomatic patients with HIV infection be treated with zidovudine?

When should asymptomatic patients with HIV infection be treated with zidovudine?

http://www.wikidata.org/entity/Q42766859

about

Partner notification for HIV infection in the United Kingdom: a look back on seven years experience in Newcastle upon Tyne.A manual bead assay for the determination of absolute CD4+ and CD8+ lymphocyte counts in human immunodeficiency virus-infected individuals.

P2860

Q33934281-A4CB3DBE-8879-410D-B24B-617EC3DCB1E2 Q35224931-C0C4777B-CAA8-4A3C-9030-E5BF3E81ECF2

P2860

When should asymptomatic patients with HIV infection be treated with zidovudine?

http://www.wikidata.org/entity/Q42766859

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

When should asymptomatic patients with HIV infection be treated with zidovudine?

@en

When should asymptomatic patients with HIV infection be treated with zidovudine?

@nl

type

label

When should asymptomatic patients with HIV infection be treated with zidovudine?

@en

When should asymptomatic patients with HIV infection be treated with zidovudine?

@nl

prefLabel

When should asymptomatic patients with HIV infection be treated with zidovudine?

@en

When should asymptomatic patients with HIV infection be treated with zidovudine?

@nl

P1433

Q42766859-52AFD656-EA5D-4B7D-83CE-C5EA934BAAA6

P1476

Q42766859-D48FFA18-C16B-48CB-9F2B-B6324704106A

P2093

Q42766859-3E59E648-B6D7-40E9-A7A9-9B2F117D567C

P2860

Q42766859-36FC5716-D2E6-4580-A0D5-95D5766CFC4F

Q42766859-3F61BE20-3599-40B2-981F-F9CC1566A417

Q42766859-4E4485F6-2CFD-4F9D-A8F6-0AE92EFD8A06

Q42766859-6C7ED78E-573D-4D91-BDE6-8F63413335F6

Q42766859-77CD8B8A-2680-4CD7-BEDB-D31E54839C5F

Q42766859-784E82ED-B928-4061-88E7-DFC25B49EE22

Q42766859-798B38A6-2492-4A1C-AE58-95894A23DF9A

Q42766859-8A942B93-4074-46E2-9408-04E25B50EF8E

Q42766859-977968C1-F363-4C60-9ABC-26F44160E21F

Q42766859-A1D43AE5-AEE7-4DE6-8C68-C5C47F8DF5EA

P304

Q42766859-73C86789-5EFE-435B-9282-61551AC55B5F

P31

Q42766859-3501cc3e-74e6-49ae-9391-1e54d0836f6a

Q42766859-59C2A02D-EED8-4DF6-9941-DEA2ADDEF99D

P356

Q42766859-F604823D-340C-43E8-B8C2-0C2937CE8FCF

P407

Q42766859-48FE9268-C743-4677-A655-429A9FBCFBD3

P433

Q42766859-D5EF6296-C128-4C85-A0C0-18AFB5EC3E79

P478

Q42766859-816A5628-22AF-4703-8F39-D8A99E1A7481

P577

Q42766859-5B256C9F-C915-4C17-960F-F5E38B9B3149

P5875

Q42766859-03DBE737-8475-42F9-8DCF-238BC6F0B4D7

P698

Q42766859-2340D243-5CA4-4454-AAEA-9FE68F5344AA

P932

Q42766859-A6C87ED7-E101-46D5-8E67-B9C7208336C3

P356

BMJ.304.6825.456

P1433

P1476

When should asymptomatic patients with HIV infection be treated with zidovudine?

@en

P2093

Gazzard BG

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging

Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.

Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.

The relationship between male circumcision and HIV infection in African populations.

Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals.

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.

Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important.

A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy.

Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS.

Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.

P304

456-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.304.6825.456

http://www.w3.org/2001/XMLSchema#string

P407

P433

6825

http://www.w3.org/2001/XMLSchema#string

P478

304

http://www.w3.org/2001/XMLSchema#string

P577

1992-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21807422

http://www.w3.org/2001/XMLSchema#string

P698

1347712

http://www.w3.org/2001/XMLSchema#string

P932

1881128

http://www.w3.org/2001/XMLSchema#string